Dr. Ariane O. Conrad currently serves as the Associate Director for Human Factors in DMEPA 1 at the FDA. In this role, she provides oversight for premarket and postmarket medication safety activities related to the human factors program. She began her career at the FDA in 2015 as a pharmacist/safety evaluator in DMEPA responsible for the premarket and postmarket review of medications to treat diabetes with the Division of Diabetes, Lipid Disorders, and Obesity (DDLO) within the Office of New Drugs.
Prior to joining the FDA, Dr. Conrad worked in pharmacy practice as a staff pharmacist, internal medicine clinical pharmacist, and as a clinical assistant professor of pharmacy practice at her alma mater, Xavier University of Louisiana, with a clinical appointment as an ambulatory care pharmacist. Her primary areas of clinical practice included diabetes, obesity, and hypertension. She earned her Doctor of Pharmacy degree from Xavier University of Louisiana College of Pharmacy, completed an ASHP accredited pharmacy practice residency with the Central Arkansas Veterans Healthcare System, and completed the FDA/ISMP Safe Medication Management fellowship. In addition, she maintains board certifications as a Clinical Pharmacy Specialist (BCACP) and Certified Diabetes Care and Education Specialist (CDCES).
